ANTIGENIC AND MOLECULAR CHARACTERIZATION OF THE FUSION GLYCOPROTEIN OF RSV
RSV 融合糖蛋白的抗原和分子特征
基本信息
- 批准号:3811254
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Respiratory syncytial virus is the common cause of lower respiratory tract
diseases in infancy. The F glycoprotein of this virus has been identified
as one of the important targets of a protective immune response, however,
immunity is incomplete and repeated infections occur. Therefore, a major
effort of this laboratory has been to evaluate antigenic variation of the
neutralization and fusion epitopes and construct a detailed molecular
epitope map of RSV F. The genes for the fusion glycoprotein of RSV-F
monoclonal antibody resistant mutants have been cloned and sequenced.
Briefly, a cDNA copy of viral mRNA was amplified by polymerase chain
reaction and cloned into M13. Sequence analysis has identified the amino
acid residues in the neutralization epitopes of antigenic sites A, B, and
C. The most dramatic substitution results in a change in charge in a site A
epitope and Garnier analysis predicts a significant alteration in the
secondary structure of the F glycoprotein. Consistent with these findings,
variants that contain this change exhibit a small plaque phenotype,
suggesting that a decrease in function has occurred as a result of a
modification in the structure of the F glycoprotein. We also compared
replication of these viruses in the cotton rat. Several of the variant
viruses, including those with a small plaque phenotype, had a decreased
ability to replicate in cotton rat lungs when compared to the parent virus.
This suggests that the F glycoprotein may be one of the determinants of
virulence and cellular tropism in vivo. Furthermore, naturally occurring
attenuated strains may exist and play a role in the development of a
complete o I partial protective immune response. Studies are under way to
more completely characterize RSV-F from these variant viruses and to
further evaluate the antibody response to this glycoprotein.
呼吸道合胞病毒是下呼吸道的常见病因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J A BEELER其他文献
J A BEELER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J A BEELER', 18)}}的其他基金
COMPATIVE IMMUNOGENICITY OF MEASLES VIRUS VACCINE STRAINS
麻疹病毒疫苗株的免疫原性比较
- 批准号:
3770339 - 财政年份:
- 资助金额:
-- - 项目类别:
ANTIGENIC AND MOLECULAR CHARACTERIZATION OF THE FUSION GLYCOPROTEIN OF RSV
RSV 融合糖蛋白的抗原和分子特征
- 批准号:
3792536 - 财政年份:
- 资助金额:
-- - 项目类别:
COMPATIVE IMMUNOGENICITY OF MEASLES VIRUS VACCINE STRAINS
麻疹病毒疫苗株的免疫原性比较
- 批准号:
3748169 - 财政年份:
- 资助金额:
-- - 项目类别:
ANTIGENIC AND MOLECULAR CHARACTERIZATION OF THE FUSION GLYCOPROTEIN OF RSV
RSV 融合糖蛋白的抗原和分子特征
- 批准号:
3804806 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
-- - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
-- - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
-- - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
-- - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
-- - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
-- - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
-- - 项目类别: